Back

A macrophage migration inhibitory factor as a predictor of no-reflow phenomenon and other adverse events in patients with st-segment elevation myocardial infarction

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Biomarkers HFA Premium Access Heart Failure 2021

About the speaker

Photo
Associate Professor Iryna Vyshnevska

Cardiovascular Research Institute Basel, Basel (Switzerland)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
The role of macrophage migration inhibitory factor in predicting left ventricular remodeling in patients with acute myocardial infarction
21 May 2022
thumbnail
Congress Presentation
Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention
27 August 2021
thumbnail
Congress Presentation
Clinical factors associated with microvascular obstruction in early presenters of ST-segment elevation myocardial infarction
28 August 2020
thumbnail
Congress Presentation
Predictive value of HCO3- on the no-reflow phenomenon in STEMI patients
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources